[HTML][HTML] Efficacy of sacubitril/valsartan versus olmesartan in Japanese patients with essential hypertension: a randomized, double-blind, multicenter study

H Rakugi, K Kario, M Yamaguchi, T Sasajima… - Hypertension …, 2022 - nature.com
This phase III study assessed the efficacy and safety of sacubitril/valsartan compared with
those of olmesartan in Japanese patients with essential hypertension. Patients (n= 1161 …

Efficacy of sacubitril/valsartan versus olmesartan in Japanese patients with essential hypertension: a randomized, double-blind, multicenter study

H Rakugi, K Kario, M Yamaguchi, T Sasajima… - Hypertension …, 2022 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> This phase III study assessed the efficacy and
safety of sacubitril/valsartan compared with those of olmesartan in Japanese patients with …

[HTML][HTML] Efficacy of sacubitril/valsartan versus olmesartan in Japanese patients with essential hypertension: a randomized, double-blind, multicenter study

H Rakugi, K Kario, M Yamaguchi, T Sasajima… - Hypertension …, 2022 - ncbi.nlm.nih.gov
This phase III study assessed the efficacy and safety of sacubitril/valsartan compared with
those of olmesartan in Japanese patients with essential hypertension. Patients (n= 1161 …

Efficacy of sacubitril/valsartan versus olmesartan in Japanese patients with essential hypertension: a randomized, double-blind, multicenter study

H Rakugi, K Kario, M Yamaguchi, T Sasajima, H Gotou… - 2022 - pubmed.ncbi.nlm.nih.gov
This phase III study assessed the efficacy and safety of sacubitril/valsartan compared with
those of olmesartan in Japanese patients with essential hypertension. Patients (n= 1161 …

Efficacy of sacubitril/valsartan versus olmesartan in Japanese patients with essential hypertension: a randomized, double-blind, multicenter study

R Hiromi, Y Masako, S Takayoshi… - Hypertension …, 2022 - search.proquest.com
This phase III study assessed the efficacy and safety of sacubitril/valsartan compared with
those of olmesartan in Japanese patients with essential hypertension. Patients (n= 1161 …

Efficacy of sacubitril/valsartan versus olmesartan in Japanese patients with essential hypertension: a randomized, double-blind, multicenter study.

H Rakugi, K Kario, M Yamaguchi… - … : Official Journal of the …, 2022 - europepmc.org
This phase III study assessed the efficacy and safety of sacubitril/valsartan compared with
those of olmesartan in Japanese patients with essential hypertension. Patients (n= 1161 …